GLP-1 Market
LLY $1152.44 ▲ +1.3% NVO $43.19 ▲ +3.5% PFE $27.64 ▲ +0.7% VKTX $29.36 ▼ -0.5% KLRA $12.92 ▲ +1.7% GPCR $35.10 ▼ -1.1% RHHBY $54.60 ▼ -1.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ezetimibe

Company
Taipei Medical University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
40 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

40 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 18, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ezetimibe and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04347434

    Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI

    Not yet reported Penza State University 300 participants Est. completion 2027-12-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Myocardial Strain, Arterial Stiffness, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT04499859

    Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

    Not yet reported Kiyuk Chang, MD,PhD 3548 participants Est. completion 2027-08-30 7 sites Stand-alone
    Cardiovascular disease Other conditions: Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity
    View official trial listing →
  • Recruiting NCT NCT04968509

    Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis

    Not yet reported Beijing Anzhen Hospital 160 participants Est. completion 2028-01 1 site Stand-alone
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Recruiting NCT NCT05103254

    Bempedoic Acid Pregnancy Surveillance Program

    Esperion Therapeutics, Inc. 20 participants Est. completion 2032-05 1 site
    Other conditions: Pregnancy, Hyperlipidemias
    View official trial listing →
  • Recruiting NCT NCT05365438

    Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

    Not yet reported Seoul National University Bundang Hospital 105 participants Est. completion 2026-12-31 1 site
    Type 2 diabetes Other conditions: Dyslipidemias, Atherosclerosis
    View official trial listing →
  • Recruiting NCT NCT05641753

    Cholesterol Lowering and Residual Risk in Diabetes, Type 1

    Not yet reported NYU Langone Health 125 participants Est. completion 2027-07-31 4 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT05705804

    Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

    Not yet reported Yonsei University 250 participants Est. completion 2027-06-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT05765370

    LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)

    Not yet reported China National Center for Cardiovascular Diseases 4200 participants Est. completion 2026-12-24 1 site Stand-alone
    Cardiovascular disease Other conditions: Older Patients, LDL Cholesterol
    View official trial listing →
  • Recruiting NCT NCT05782777

    Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial

    Not yet reported Yonsei University 4310 participants Est. completion 2027-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT05845424

    High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

    Not yet reported Samsung Medical Center 6000 participants Est. completion 2030-06-30 1 site Stand-alone
    Metabolic syndrome Other conditions: Coronary Artery Calcification, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT06186037

    Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention

    Not yet reported Saint Vincent's Hospital, Korea 6356 participants Est. completion 2029-02-28 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Primary Prevention
    View official trial listing →
  • Recruiting NCT NCT06231966

    Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)

    Not yet reported Yonsei University 2462 participants Est. completion 2029-05-06 1 site Stand-alone
    Other conditions: Peripheral Artery Disease, Polyvascular Disease
    View official trial listing →
  • Recruiting NCT NCT06293417

    To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM

    Not yet reported Korea University Anam Hospital 3958 participants Est. completion 2027-02-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT06314919

    A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

    Boryung Pharmaceutical Co., Ltd 8606 participants Est. completion 2026-06 1 site
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT06437574

    Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

    Not yet reported Cedars-Sinai Medical Center 140 participants Est. completion 2028-05-31 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06501443

    LATAM LOWERS LDL-C

    Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Recruiting NCT NCT06604117

    Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

    Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 site
    Cardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, Statin
    View official trial listing →
  • Recruiting NCT NCT06649240

    Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

    Not yet reported Seoul National University Hospital 4016 participants Est. completion 2030-09 46 sites Stand-alone
    Cardiovascular disease Other conditions: Small Vessel Cerebrovascular Disease, Cholesterol, LDL, Secondary Prevention
    View official trial listing →
  • Recruiting NCT NCT06686615

    A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sites
    Other conditions: Primary Hypercholesterolemiia, Mixed Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT06722521

    GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification

    Not yet reported Asan Medical Center 7435 participants Est. completion 2032-10-31 1 site Stand-alone
    Other conditions: Primary Prevention, Vascular Calcification
    View official trial listing →
  • Recruiting NCT NCT06738758

    Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)

    Yun Dai Chen 6000 participants Est. completion 2027-12-31 1 site
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Recruiting NCT NCT06767345

    Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

    Not yet reported Korea University Anam Hospital 408 participants Est. completion 2028-06-25 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis of Coronary Artery, Plaque, Atherosclerotic
    View official trial listing →
  • Recruiting NCT NCT06767774

    Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

    Not yet reported Korea University Anam Hospital 2000 participants Est. completion 2030-01-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Diabetes, Statin
    View official trial listing →
  • Recruiting NCT NCT06784557

    Effect of Ezetimibe on Gut Microbiota

    Not yet reported Yonsei University 110 participants Est. completion 2025-10-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06789432

    Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

    Not yet reported Dr. Md. Alimur Reza 500 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Hyperlipidemia (E.G., Hypercholesterolemia)
    View official trial listing →
  • Recruiting NCT NCT06858332

    Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

    Novartis Pharmaceuticals 2382 participants Est. completion 2027-09-30 20 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06896708

    Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome

    Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-alone
    Other conditions: Chronic Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT06930092

    RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy

    Not yet reported Seoul National University Hospital 158 participants Est. completion 2029-04-30 1 site
    Other conditions: Ischemic Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07036991

    A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis

    Changhai Hospital 406 participants Est. completion 2027-06-01 1 site
    Other conditions: Carotid Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT07083206

    A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

    Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07206472

    A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

    Daiichi Sankyo 2120 participants Est. completion 2028-12-31 23 sites
    Other conditions: Primary Hypercholesterolaemia, Mixed Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT07208006

    Very Early PCSK9 Inhibition for Acute Myocardial Infarction

    Not yet reported Shanghai Zhongshan Hospital 1518 participants Est. completion 2028-10-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07307989

    Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

    Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2029-07-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypercholesteremia
    View official trial listing →
  • Recruiting NCT NCT07359105

    Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

    Not yet reported Sin Gon Kim 2186 participants Est. completion 2029-12-31 2 sites Stand-alone
    Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07447648

    Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

    Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 52 participants Est. completion 2029-02 13 sites
    Other conditions: Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography
    View official trial listing →
  • Recruiting NCT NCT07523971

    Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

    JW Pharmaceutical 10000 participants Est. completion 2027-06 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07524101

    Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

    Not yet reported Yonsei University 1952 participants Est. completion 2031-01-22 1 site Stand-alone
    Cardiovascular disease Other conditions: Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Recruiting NCT NCT07679828

    Polypills Approach for Multiple Cardiovascular Risk Factors

    Not yet reported China Medical University, China 8252 participants Est. completion 2030-03-01 15 sites Stand-alone
    Other conditions: Hypertension, Dyslipidemia, Diabetes
    View official trial listing →
  • Recruiting NCT NCT07704918

    Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

    Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Melanoma
    View official trial listing →
  • Recruiting NCT NCT07824323

    Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome

    Not yet reported Taipei Medical University Hospital 400 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00045812

    SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 5 participants Est. completion 2004-04 1 site
    Other conditions: Lipoidosis
    View official trial listing →
  • Completed NCT NCT00079638

    Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

    Not yet reported Kos Pharmaceuticals 300 participants Est. completion 2005-05
    Cardiovascular disease Other conditions: Dyslipidemia, Coronary Heart Disease, Atherosclerosis, Diabetes
    View official trial listing →
  • Completed NCT NCT00090168

    Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

    Not yet reported Organon and Co 435 participants Est. completion 2004-11-10
    Other conditions: Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00090298

    Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)

    Not yet reported Organon and Co 2815 participants Est. completion 2004-12
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092560

    Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

    Not yet reported Organon and Co 587 participants Est. completion 2003-12
    Other conditions: Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00092573

    Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

    Not yet reported Organon and Co 576 participants Est. completion 2004-11
    Other conditions: Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00092586

    Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

    Not yet reported Organon and Co 2904 participants Est. completion 2003-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092599

    Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

    Not yet reported Organon and Co 410 participants Est. completion 2004-07
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092612

    Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

    Not yet reported Organon and Co 372 participants Est. completion 2004-06
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092625

    Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

    Not yet reported Organon and Co 442 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092638

    An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

    Not yet reported Organon and Co 450 participants Est. completion 2004-08
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00092651

    A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

    Not yet reported Organon and Co 1398 participants Est. completion 2003-06
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092664

    An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)

    Not yet reported Organon and Co 1104 participants Est. completion 2003-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092677

    An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)

    Not yet reported Organon and Co 1873 participants Est. completion 2008-04 Stand-alone
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT00092690

    MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)

    Not yet reported Organon and Co 1902 participants Est. completion 2004-03
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092716

    Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)

    Not yet reported Organon and Co 655 participants Est. completion 2003-04
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00092807

    Sitosterolemia Extension Study (0653-003)(COMPLETED)

    Not yet reported Organon and Co 37 participants Est. completion 2004-11-30
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Completed NCT NCT00092820

    Sitosterolemia Extension Study (0653-004)(COMPLETED)

    Not yet reported Organon and Co 58 participants Est. completion 2004-11-30
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Terminated NCT NCT00092833

    Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

    Not yet reported Organon and Co 49 participants Est. completion 2005-05 Stand-alone
    Other conditions: Hypercholesterolemia, Familial, Lipid Metabolism, Inborn Errors
    View official trial listing →
  • Completed NCT NCT00092898

    An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

    Not yet reported Organon and Co 30 participants Est. completion 2005-10
    Other conditions: Lipid Metabolism, Inborn Errors, Heart Disease
    View official trial listing →
  • Completed NCT NCT00093899

    A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

    Not yet reported Organon and Co 611 participants Est. completion 2005-09
    Other conditions: Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT00099684

    Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 44 participants Est. completion 2007-05 42 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00099996

    Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 3 participants Est. completion 2005-12 1 site
    Other conditions: Heart Diseases, Metabolism, Inborn Errors
    View official trial listing →
  • Completed NCT NCT00101439

    A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)

    Not yet reported Organon and Co 58 participants Est. completion 2006-11-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00110435

    A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)

    Not yet reported Organon and Co 1229 participants Est. completion 2005-12
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00120289

    Niacin Plus Statin to Prevent Vascular Events

    Not yet reported Axio Research. LLC 3414 participants Est. completion 2012-12 91 sites Stand-alone
    Cardiovascular disease Other conditions: Heart Diseases, Cerebrovascular Accident, Coronary Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00125593

    Study of Heart and Renal Protection

    Not yet reported University of Oxford 9438 participants Est. completion 2010-08 1 site
    Other conditions: Kidney Disease, Chronic
    View official trial listing →
  • Completed NCT NCT00127218

    High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly

    Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00129402

    Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)

    Not yet reported Organon and Co 248 participants Est. completion 2007-06 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00132717

    A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

    Not yet reported Organon and Co 450 participants Est. completion 2007-06-01
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00157482

    Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

    Not yet reported Mario Negri Institute for Pharmacological Research 108 participants Est. completion 2006-12 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00157911

    A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

    Not yet reported Organon and Co 136 participants Est. completion 2003-12
    Other conditions: Hypercholerolemia
    View official trial listing →
  • Completed NCT NCT00157924

    Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

    Not yet reported Organon and Co 190 participants Est. completion 2007-09 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00166504

    Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)

    Not yet reported Organon and Co 203 participants Est. completion 2007-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00166530

    EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)

    Not yet reported Organon and Co 367 participants Est. completion 2007-02 Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00171288

    Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin Alone

    Not yet reported Novartis 83 participants Est. completion 2005-08 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00185107

    Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol

    Not yet reported Daiichi Sankyo 45 participants Est. completion 2005-10 7 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00189085

    Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function

    Not yet reported UMC Utrecht 20 participants Est. completion 2005-07 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00195793

    A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

    Not yet reported Abbott 174 participants
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00202878

    IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)

    Not yet reported Organon and Co 18144 participants Est. completion 2014-09-18 Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00202904

    Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)

    Not yet reported Organon and Co 81 participants Est. completion 2006-10 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00203476

    A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

    Not yet reported Tuscaloosa Research & Education Advancement Corporation 30 participants Est. completion 2008-01 1 site
    Other conditions: Hyperlipidemia, Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00267267

    A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

    Not yet reported Pfizer 1784 participants Est. completion 2007-01 123 sites
    Other conditions: Hyperlipidemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00268697

    Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

    Not yet reported Takeda 1267 participants Est. completion 2007-01 9 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00271817

    To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

    Not yet reported Organon and Co 1220 participants Est. completion 2008-02
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00276458

    To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

    Not yet reported Organon and Co 196 participants Est. completion 2008-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00276484

    To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

    Not yet reported Organon and Co 579 participants Est. completion 2008-03 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00299884

    Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

    Queen's University 45 participants Est. completion 2006-07 1 site
    Other conditions: Dyslipidemia, Vascular Disease
    View official trial listing →
  • Completed NCT NCT00317993

    LDL Receptor Under Ezetimibe and Simvastatin

    Not yet reported University of Cologne 60 participants Est. completion 2004-07 1 site
    Other conditions: Healthy Men
    View official trial listing →
  • Completed NCT NCT00319449

    Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

    Not yet reported Organon and Co 22 participants Est. completion 2006-10 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Arteriosclerosis
    View official trial listing →
  • Completed NCT NCT00328523

    TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

    Not yet reported Organon and Co 1496 participants Est. completion 2006-01
    Other conditions: Hypercholesterolaemia, Hyperlipidaemia
    View official trial listing →
  • Completed NCT NCT00349284

    A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome

    Not yet reported Solvay Pharmaceuticals 181 participants 43 sites
    Other conditions: Hyperlipidemia Combined
    View official trial listing →
  • Completed NCT NCT00359281

    Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents

    Not yet reported Aegerion Pharmaceuticals, Inc. 125 participants Est. completion 2007-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00376246

    Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects

    Not yet reported University of California, San Diego 28 participants Est. completion 2008-04
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00385658

    Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

    Not yet reported Novartis 75 participants Est. completion 2007-03 2 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00395473

    Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

    Not yet reported Organon and Co 141 participants Est. completion 2005-11
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00395603

    Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)

    Not yet reported Organon and Co 550 participants Est. completion 2007-06
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00397657

    Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

    Not yet reported Walter Reed Army Medical Center 400 participants Est. completion 2009-10 2 sites
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00405067

    The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia

    Not yet reported Aegerion Pharmaceuticals, Inc. 60 participants Est. completion 2007-01 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00408057

    Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )

    Canadian Heart Research Centre 2500 participants Est. completion 2007-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00409773

    Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)

    Not yet reported Organon and Co 1143 participants Est. completion 2008-07
    Metabolic syndrome Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00413972

    Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)

    Not yet reported Organon and Co 392 participants Est. completion 2006-11 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00418834

    Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

    Not yet reported Organon and Co 1053 participants Est. completion 2008-10
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00423488

    Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

    Not yet reported Organon and Co 93 participants Est. completion 2007-02-16 Stand-alone
    Type 2 diabetes Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00423579

    The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)

    Not yet reported Organon and Co 120 participants Est. completion 2008-03-01 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Disease
    View official trial listing →
  • Status unknown NCT NCT00433823

    A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis

    Not yet reported Abant Izzet Baysal University Est. completion 2008-01 1 site
    Other conditions: Coronary Heart Disease, Diabetes Mellitus, Non-Coronary Atherosclerotic Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00440154

    A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia

    Not yet reported Sanofi 206 participants Est. completion 2007-10 6 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00442897

    Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

    Not yet reported Organon and Co 229 participants Est. completion 2008-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00449410

    Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients

    Not yet reported Radboud University Medical Center 35 participants Est. completion 2006-10 1 site
    Other conditions: Atrial Fibrillation, Neuropsychology, Magnetic Resonance Imaging, Inflammation, Hemostasis
    View official trial listing →
  • Completed NCT NCT00457275

    Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)

    Not yet reported Organon and Co 440 participants Est. completion 2005-11
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00461630

    Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE

    Not yet reported University of Oxford 25673 participants Est. completion 2012-10 1 site Stand-alone
    Cardiovascular disease Other conditions: Peripheral Arterial Disease, Diabetes Mellitus, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00461968

    Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both

    Not yet reported University of Texas Southwestern Medical Center 240 participants Est. completion 2007-04 1 site
    Other conditions: Cholesterol, LDL
    View official trial listing →
  • Completed NCT NCT00462748

    A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

    Not yet reported Organon and Co 786 participants Est. completion 2008-06 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00466401

    Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation

    Not yet reported Ziv Hospital 20 participants Est. completion 2007-08 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00474123

    Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe

    Not yet reported University of Sao Paulo 78 participants Est. completion 2009-08 1 site
    Other conditions: Stable Angina
    View official trial listing →
  • Status unknown NCT NCT00475826

    Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe

    Not yet reported University of Sao Paulo 1 site
    Other conditions: Heterozigous Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00477204

    Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes

    Not yet reported University of Colorado, Denver 9 participants Est. completion 2010-08 1 site
    Other conditions: Type 1 Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00479713

    A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

    Not yet reported Organon and Co 618 participants Est. completion 2008-03-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00481351

    Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons

    Not yet reported University of Sao Paulo 25 participants Est. completion 2010-01 Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00485121

    Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis

    Not yet reported Canadian Collaborative Research Network 50 participants Est. completion 2009-04 1 site
    Metabolic syndromeCardiovascular disease Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00496730

    A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)

    Not yet reported Organon and Co 256 participants Est. completion 2008-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00525824

    12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

    Not yet reported AstraZeneca 1743 participants Est. completion 2008-09 9 sites
    Other conditions: Hypercholesterolemia, Coronary Heart Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00535405

    A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

    Not yet reported Organon and Co 1289 participants Est. completion 2009-03 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00541697

    Eze/Simva Switch Study in Diabetics (0653A-807)

    Not yet reported Organon and Co 648 participants Est. completion 2005-10-14
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00548145

    The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease

    Not yet reported Osaka University 38 participants Est. completion 2012-03 1 site
    Other conditions: Alzheimer Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00551447

    A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

    Not yet reported Organon and Co 616 participants Est. completion 2003-03
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00551876

    Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)

    Not yet reported Organon and Co 214 participants Est. completion 2003-01
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00552097

    Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

    Not yet reported Organon and Co 720 participants Est. completion 2006-04-25 Stand-alone
    Other conditions: Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II
    View official trial listing →
  • Completed NCT NCT00559962

    Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

    Not yet reported Aegerion Pharmaceuticals, Inc. 260 participants Est. completion 2008-11 15 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00560170

    Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis

    Not yet reported National Cheng-Kung University Hospital 40 participants Est. completion 2008-02 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00566267

    A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet

    Not yet reported, Not yet reported Merck Sharp & Dohme LLC 58 participants Est. completion 2007-11 Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00587678

    Comprehensive Magnetic Resonance of Peripheral Arterial Disease

    Not yet reported University of Virginia 85 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Completed NCT NCT00621101

    Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

    Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-06 1 site Stand-alone
    Other conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00621699

    Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects

    Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT00634140

    The Influence of Ezetimibe on Gallbladder Function

    Not yet reported Indiana University Est. completion 2009-08 1 site Stand-alone
    Other conditions: Chronic Acalculous Cholecystitis
    View official trial listing →
  • Completed NCT NCT00639158

    Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

    Not yet reported Abbott 543 participants 118 sites
    Other conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00650663

    Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)

    Not yet reported Organon and Co 247 participants Est. completion 2004-09-01 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00650689

    Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

    Not yet reported Organon and Co 122 participants Est. completion 2004-12 Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00650819

    Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)

    Not yet reported Organon and Co 240 participants Est. completion 2005-02-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00651014

    Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)

    Not yet reported Organon and Co 82 participants Est. completion 2006-06 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00651144

    Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)

    Not yet reported Organon and Co 40 participants Est. completion 2003-05 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00651274

    Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)

    Not yet reported Organon and Co 144 participants Est. completion 2004-08-01 Stand-alone
    Other conditions: Atherosclerosis, Hypercholesterolemia, Coronary Heart Disease
    View official trial listing →
  • Terminated NCT NCT00651378

    Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

    Not yet reported Organon and Co 87 participants Est. completion 2005-06-01
    Cardiovascular disease Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Terminated NCT NCT00651391

    Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)

    Not yet reported Organon and Co 28 participants Est. completion 2004-09-01 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00651404

    Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)

    Not yet reported Organon and Co 137 participants Est. completion 2004-12 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00651560

    Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)

    Not yet reported Organon and Co 167 participants Est. completion 2005-12-23
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00651963

    Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

    Not yet reported Organon and Co 80 participants Est. completion 2005-03
    Other conditions: Lipid Metabolism Disorder
    View official trial listing →
  • Completed NCT NCT00652301

    A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

    Not yet reported Organon and Co 40 participants Est. completion 2004-04 Stand-alone
    Other conditions: Cholesterol
    View official trial listing →
  • Completed NCT NCT00652327

    Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)

    Not yet reported Organon and Co 83 participants Est. completion 2007-07 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00652431

    Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

    Not yet reported Organon and Co 18 participants Est. completion 2007-07 Stand-alone
    Other conditions: Hypercholesterolemia, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00652444

    Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)

    Not yet reported Organon and Co 120 participants Est. completion 2004-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00652717

    Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

    Not yet reported Organon and Co 280 participants Est. completion 2005-08-04 Stand-alone
    Other conditions: Cardiovascular Disorder
    View official trial listing →
  • Completed NCT NCT00652847

    Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

    Not yet reported Organon and Co 1140 participants Est. completion 2007-05 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00653276

    MD Ezetimibe Cyclosporine Interaction (0653-057)

    Not yet reported Organon and Co 13 participants Est. completion 2004-01
    Other conditions: Cholesterol
    View official trial listing →
  • Completed NCT NCT00653445

    Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg

    Not yet reported AstraZeneca Est. completion 2005-06 Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Heart Disease, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653523

    Coadministration of Ezetimibe and Simvastatin in Patients With Primary Hypercholesterolemia (P05457)

    Not yet reported Organon and Co 151 participants Est. completion 2009-06-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00653796

    Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

    Not yet reported Organon and Co 148 participants Est. completion 2004-08-01 Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653835

    Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

    Not yet reported Organon and Co 153 participants Est. completion 2004-08-01 Stand-alone
    Other conditions: Hypercholesterolaemia, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00653913

    Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)

    Not yet reported Organon and Co 18 participants Est. completion 2004-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654095

    Coadministration of Ezetimibe and Atorvastatin in Patients With Primary Hypercholesterolemia (P05456)

    Not yet reported Organon and Co 146 participants Est. completion 2009-06-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00654628

    Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)

    Not yet reported Organon and Co 173 participants Est. completion 2009-07-01 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT00664469

    INdians Followed for INtensive Lipid Lowering Treatment and Its safetY

    Not yet reported Sunnybrook Health Sciences Centre 64 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00677248

    LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

    Not yet reported Karo Bio AB 120 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00679237

    Risk Reduction in Coronary Heart Disease

    Not yet reported Sorlandet Hospital HF 1600 participants Est. completion 2019-12 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00681525

    A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

    Not yet reported Abbott 18 participants 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00687076

    Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)

    Not yet reported Baylor College of Medicine 102 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00699023

    Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

    Not yet reported Federico II University 13 participants Est. completion 2009-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Postprandial Lipemia
    View official trial listing →
  • Completed NCT NCT00701727

    Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study

    Not yet reported Radiant Research 31 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00704444

    A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)

    Organon and Co 11332 participants Est. completion 2009-09
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia, Homozygous Sitosterolemia
    View official trial listing →
  • Completed NCT NCT00704535

    Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)

    Organon and Co 4105 participants Est. completion 2008-04
    Other conditions: Primary Hypercholesterolemia, Homozygous Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00705081

    Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)

    Organon and Co 453 participants Est. completion 2007-12
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00705211

    A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

    Organon and Co 1794 participants Est. completion 2009-12
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia, Homozygous Sitosterolemia
    View official trial listing →
  • Completed NCT NCT00724477

    Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

    Organon and Co 1663 participants Est. completion 2008-08
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00725829

    Hypolipemic Treatment in Acute Coronary Syndrome (ACS): Antithrombotic Effects

    Not yet reported Jagiellonian University 100 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00726856

    Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

    Organon and Co 1200 participants Est. completion 2007-07
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00730132

    Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)

    Organon and Co 712 participants Est. completion 2009-08
    Other conditions: Coronary Heart Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00738296

    Vytorin on Carotid Intima-media Thickness and Overall Rigidity

    Not yet reported Hospital Universitario 12 de Octubre 90 participants Est. completion 2005-12 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00738972

    Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

    Not yet reported Fundación Lindavista del Corazón AC 12 participants Est. completion 2010-08 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00738985

    Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Est. completion 2010-09
    Cardiovascular disease Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00753883

    Ezetrol Post-Marketing Study

    Not yet reported Merck Sharp & Dohme LLC 40 participants
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00762164

    Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

    Not yet reported Bronx VA Medical Center 34 participants Est. completion 2009-05 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00762229

    Evaluation of LDL Cholesterol in Patients Switched From 10 to 5 Milligrams of Zetia (Ezetimibe)

    Not yet reported Bronx VA Medical Center 39 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00772551

    Raltegravir and Ezetimibe PK Study

    Not yet reported St Stephens Aids Trust 26 participants Est. completion 2008-08 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT00782184

    Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

    Not yet reported Organon and Co 250 participants Est. completion 2010-09 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00783263

    A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

    Not yet reported Organon and Co 440 participants Est. completion 2010-05 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00794677

    Effects of Ezetimibe on the Absorption of Oxidized Cholesterol

    Not yet reported UCSF Benioff Children's Hospital Oakland 26 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00810303

    Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2

    Not yet reported University Medicine Greifswald 12 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Pharmacokinetics, Drug Interactions, Pharmacodynamics, Intestinal Transporter Expression
    View official trial listing →
  • Completed NCT NCT00814723

    Fluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular Risk

    Not yet reported Medical University of Graz 90 participants Est. completion 2007-09 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00817843

    The PostprAndial eNdothelial Function After Combination of Ezetimibe and simvAstatin Study

    Not yet reported dr.Frank L.J. Visseren 100 participants Est. completion 2010-09 5 sites Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00819403

    Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

    Not yet reported University of Maryland, Baltimore 15 participants Est. completion 2011-11 3 sites
    Metabolic syndrome
    View official trial listing →
  • Status unknown NCT NCT00843661

    Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

    Not yet reported Ospedale di Circolo - Fondazione Macchi 60 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: HIV, Hyperlipidemia, HIV Infections
    View official trial listing →
  • Status unknown NCT NCT00861731

    Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy

    Not yet reported Azienda Ospedaliero Universitaria di Sassari 30 participants Est. completion 2009-07 1 site
    Other conditions: Hypercholesterolemia, Chronic Nephropathy
    View official trial listing →
  • Completed NCT NCT00862251

    Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)

    Not yet reported Organon and Co 808 participants Est. completion 2011-03 Stand-alone
    Other conditions: Cardiovascular Disorder, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00863265

    Phytosterols, Ezetimibe, and Cholesterol Metabolism

    Not yet reported Washington University School of Medicine 22 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00867165

    Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)

    Not yet reported Organon and Co 138 participants Est. completion 2012-04-13 Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00871351

    Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)

    Not yet reported Organon and Co 125 participants Est. completion 2010-05-01 Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00879710

    Effect of Diabetes Mellitus on Cholesterol Metabolism

    Not yet reported Medical College of Wisconsin 57 participants Est. completion 2013-07 1 site
    Type 2 diabetes Other conditions: Type 1 Diabetes Mellitus, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00905905

    Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction

    Not yet reported Brasilia Heart Study Group 40 participants Est. completion 2010-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00908011

    Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

    Not yet reported University of British Columbia 43 participants Est. completion 2015-01 1 site
    Other conditions: Hypercholesterolemia, HIV Infections
    View official trial listing →
  • Completed NCT NCT00909389

    Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647)

    Organon and Co 4748 participants Est. completion 2008-11
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT00926055

    Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

    Not yet reported Korea University 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00932620

    Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)

    Not yet reported University of Ioannina 100 participants Est. completion 2010-04 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT00952770

    Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty

    Not yet reported Chungnam National University 140 participants 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00955227

    Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels

    Not yet reported University of Manitoba 60 participants Est. completion 2015-12 2 sites Stand-alone
    Other conditions: Hypercholesterolemia, Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT00965055

    Ezetimibe in Patients Hypo-responsive to Statins

    Not yet reported University of California, San Diego 2 participants Est. completion 2012-09 1 site Stand-alone
    Cardiovascular disease Other conditions: High Cholesterol
    View official trial listing →
  • Status unknown NCT NCT00972829

    Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia

    Not yet reported Bronx VA Medical Center 30 participants Est. completion 2011-03 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00988364

    Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.

    Not yet reported Baylor College of Medicine 30 participants Est. completion 2008-02 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT01008345

    Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol

    Not yet reported Hotel Dieu de France Hospital 100 participants Est. completion 2009-06 1 site Stand-alone
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01035320

    Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment

    Not yet reported Karolinska Institutet 39 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Impaired Renal Function
    View official trial listing →
  • Completed NCT NCT01043380

    Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound

    Not yet reported Kumamoto University 245 participants Est. completion 2014-09 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01047501

    Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

    Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01047683

    Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

    Not yet reported Amarin Pharma Inc. 229 participants Est. completion 2011-07 60 sites
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Status unknown NCT NCT01068093

    The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome

    Not yet reported Yokohama City University Medical Center 120 participants Est. completion 2015-10 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01070953

    EZETROL® Re-examination Study (MK0653-175)(COMPLETED)

    Organon and Co 4467 participants Est. completion 2010-07
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01070966

    Vytorin Reexamination Study (0653A-174)

    Organon and Co 2089 participants Est. completion 2010-04
    Other conditions: Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
    View official trial listing →
  • Completed NCT NCT01077830

    An Observational Follow-Up Study of the Incidence of Cancer and Mortality in Patients From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Trial (MK-0653A-043-10)

    Organon and Co 1392 participants Est. completion 2013-04
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT01086020

    Atorvastatin Plus Ezetimibe on Coronary Plaque Progression

    Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2012-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01103648

    Effect of Simvastatin and Ezetimibe on Lipid and Inflammation

    Not yet reported Federal University of São Paulo 50 participants Est. completion 2007-11 1 site Stand-alone
    Prediabetes Other conditions: Hypercholesterolemia, Inflammation, Cardiovascular Risk
    View official trial listing →
  • Completed NCT NCT01112423

    Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

    Not yet reported Bristol-Myers Squibb 60 participants Est. completion 2010-12 12 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01154036

    MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)

    Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01164397

    Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients

    AstraZeneca 268 participants Est. completion 2010-12 9 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT01185236

    Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

    Not yet reported Seoul National University Hospital 132 participants Est. completion 2011-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01218204

    A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

    Not yet reported GlaxoSmithKline 287 participants Est. completion 2011-06-29 21 sites Stand-alone
    Other conditions: Dyslipidaemias, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01236430

    A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)

    Not yet reported Organon and Co 200 participants Est. completion 2012-02 Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT01241097

    Pleiotropism of Statin Therapy in High Dose Versus Low Dose Combined With Ezetimibe

    Not yet reported Federal University of Bahia 60 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Endothelial Function
    View official trial listing →
  • Completed NCT NCT01266876

    Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia

    Not yet reported Regeneron Pharmaceuticals 77 participants Est. completion 2011-11 22 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT01308203

    Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

    Not yet reported Daniel A. Siniawski 32 participants Est. completion 2013-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT01370590

    A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

    Not yet reported Organon and Co 406 participants Est. completion 2012-04 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01370603

    A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

    Not yet reported Organon and Co 328 participants Est. completion 2012-05 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01375764

    Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

    Not yet reported Amgen 160 participants Est. completion 2012-05-08 42 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01375777

    Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

    Not yet reported Amgen 411 participants Est. completion 2012-03-02 58 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01381679

    Effect of Ezetimibe Treatment on Low-density Lipoprotein Cholesterol (LDL-C) Levels in Participants With Coronary Heart Disease (CHD) Already Treated With a Statin (MK-0653A-205 AM1)

    Organon and Co 1682 participants Est. completion 2010-12
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01384058

    Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes

    Not yet reported University Hospital Freiburg 41 participants Est. completion 2010-06 2 sites
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01385631

    Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

    Not yet reported Odense University Hospital 87 participants Est. completion 2014-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01414192

    A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)

    Organon and Co 3215 participants Est. completion 2014-09-15
    Other conditions: Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01420328

    To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

    Not yet reported University at Buffalo 20 participants Est. completion 2016-07-01 1 site
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT01420549

    Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

    Not yet reported Ache Laboratorios Farmaceuticos S.A. 129 participants Est. completion 2014-11 7 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01424891

    Effects on NF-κB Activity: High Dose Simvastatin Versus Combination Therapy With Ezetimibe

    Not yet reported Heidelberg University 31 participants Est. completion 2011-08 1 site
    Type 2 diabetes Other conditions: Inflammation
    View official trial listing →
  • Status unknown NCT NCT01490229

    Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2016-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01492361

    A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin

    Not yet reported Amarin Pharma Inc. 8179 participants Est. completion 2018-05 410 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01516879

    Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study

    Not yet reported Amgen 905 participants Est. completion 2013-10-14 96 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01520077

    Vytorin in the Treatment of Alopecia Areata

    Not yet reported University of Miami 29 participants Est. completion 2015-01 1 site
    Other conditions: Alopecia Areata
    View official trial listing →
  • Completed NCT NCT01584206

    Sitosterolemia Metabolism

    Not yet reported University of Manitoba 8 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Sitosterolemia
    View official trial listing →
  • Withdrawn NCT NCT01587235

    A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)

    Not yet reported Organon and Co Est. completion 2014-05 Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01597700

    Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

    Not yet reported GlaxoSmithKline 52 participants Est. completion 2012-01-30 1 site Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT01603758

    Physiological Study of Human Cholesterol Metabolism and Excretion

    Not yet reported Richard E. Ostlund Jr., MD 132 participants Est. completion 2015-06 1 site
    Cardiovascular disease Other conditions: Coronary Heart Disease, Dyslipidemia, Disorder of Cholesterol Metabolism
    View official trial listing →
  • Completed NCT NCT01611883

    A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

    Not yet reported Organon and Co 152 participants Est. completion 2014-01-16 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01644188

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)

    Not yet reported Sanofi 720 participants Est. completion 2015-07 126 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01644474

    Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia

    Not yet reported Sanofi 103 participants Est. completion 2013-07 8 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01660945

    Vascular and Metabolic Effects of Vytorin

    Not yet reported Gachon University Gil Medical Center 204 participants Est. completion 2012-11 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01666067

    Vascular and Metabolic Effects of Vytorin vs Simvastatin

    Not yet reported Gachon University Gil Medical Center 204 participants Est. completion 2012-11 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01709513

    Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)

    Not yet reported Regeneron Pharmaceuticals 314 participants Est. completion 2017-05-31 70 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01723735

    Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects

    Not yet reported Sanofi 79 participants Est. completion 2013-07 2 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01730040

    Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)

    Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01730053

    Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

    Not yet reported Regeneron Pharmaceuticals 305 participants Est. completion 2014-05-31 93 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01763827

    Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2

    Not yet reported Amgen 615 participants Est. completion 2013-10-29 83 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01763866

    LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

    Not yet reported Amgen 2067 participants Est. completion 2013-12-04 244 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01763905

    Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2

    Not yet reported Amgen 307 participants Est. completion 2013-11-19 58 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01766713

    Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

    Not yet reported University of California, San Diego 50 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Non Alcoholic Steatohepatitis
    View official trial listing →
  • Status unknown NCT NCT01807078

    Cholesterol-lowering Effects of nutraceuticaLs Versus Ezetimibe in Statin-intolerant Patients

    Not yet reported University of Roma La Sapienza 200 participants Est. completion 2017-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01849068

    Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study

    Not yet reported Laval University 20 participants Est. completion 2016-02 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT01857843

    Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

    Not yet reported Yonsei University 160 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT01890889

    Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health

    Not yet reported Integrative Health Technologies, Inc. 150 participants Est. completion 2013-12 1 site
    Other conditions: Cholesterol, Hyperlipidemia, Hypercholesteremia
    View official trial listing →
  • Completed NCT NCT01890967

    A Study of LY3015014 in Participants With High Cholesterol

    Not yet reported Eli Lilly and Company 527 participants Est. completion 2014-06 49 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01941836

    Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients

    Not yet reported Esperion Therapeutics, Inc. 349 participants Est. completion 2014-11 68 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT01950884

    Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis

    Not yet reported University of Palermo 45 participants Est. completion 2014-12 1 site Stand-alone
    MASH
    View official trial listing →
  • Completed NCT NCT01984424

    Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3

    Not yet reported Amgen 511 participants Est. completion 2017-11-21 58 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02023879

    Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

    Not yet reported Sanofi 233 participants Est. completion 2017-06-30 43 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02029625

    Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

    Not yet reported NVP Healthcare 41 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02055976

    Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

    Not yet reported Pfizer 218 participants Est. completion 2015-01 9 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02089867

    Plant Sterols Effect on Previous Statin Therapy

    Not yet reported, Not yet reported Jose Rocha Faria Neto 47 participants Est. completion 2008-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02103049

    The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients

    Not yet reported University Medical Centre Ljubljana 80 participants Est. completion 2015-12 1 site
    Other conditions: Dyslipidemia, Transplants
    View official trial listing →
  • Status unknown NCT NCT02126137

    Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection

    Not yet reported Pontificia Universidad Catolica de Chile 20 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02127320

    Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

    Not yet reported Hanmi Pharmaceutical Company Limited 24 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02129231

    Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy

    Not yet reported University of Guadalajara 74 participants Est. completion 2014-04 1 site
    Other conditions: Oxidative Stress, Diabetic Polyneuropathy
    View official trial listing →
  • Terminated NCT NCT02205775

    Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty

    Not yet reported G. d'Annunzio University 280 participants Est. completion 2012-06 6 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02227784

    A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

    Not yet reported Eli Lilly and Company 366 participants Est. completion 2015-12 64 sites
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02234544

    Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels

    Not yet reported Federal University of Rio Grande do Sul 52 participants Est. completion 2015-04 1 site
    Other conditions: Vitamin D Deficiency
    View official trial listing →
  • Terminated NCT NCT02244944

    Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

    Not yet reported Gregory Graf, PhD 2 participants Est. completion 2015-09 1 site Stand-alone
    MASLD
    View official trial listing →
  • Status unknown NCT NCT02251847

    The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients

    Not yet reported IlDong Pharmaceutical Co Ltd 400 participants 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT02260648

    A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

    Not yet reported Eli Lilly and Company 149 participants Est. completion 2015-11 8 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02288338

    CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

    Not yet reported Chong Kun Dang Pharmaceutical 36 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02289430

    to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

    Not yet reported NVP Healthcare 59 participants Est. completion 2015-02 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02304926

    Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia

    Not yet reported Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 42 participants Est. completion 2011-12 Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02445352

    Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

    Not yet reported Alvogen Korea 379 participants Est. completion 2015-03 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02451098

    Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

    Not yet reported Chong Kun Dang Pharmaceutical 385 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02460159

    A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384)

    Not yet reported Organon and Co 135 participants Est. completion 2016-12-22
    Other conditions: Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02461004

    CKD-391 Pharmacokinetic Study

    Not yet reported Chong Kun Dang Pharmaceutical 52 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02476006

    Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)

    Not yet reported Sanofi 998 participants Est. completion 2019-04-12 153 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02501200

    CKD-391 Pharmacokinetic Study Phase I

    Not yet reported Chong Kun Dang Pharmaceutical 46 participants Est. completion 2015-12 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02534376

    Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal

    Not yet reported Cedars-Sinai Medical Center 63 participants Est. completion 2019-02-28 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02547402

    A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

    Not yet reported Complexa, Inc. 10 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Status unknown NCT NCT02548936

    Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02550288

    A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)

    Not yet reported Organon and Co 309 participants Est. completion 2016-05-30 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02584504

    Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin

    Not yet reported Sanofi 163 participants Est. completion 2018-01-09 30 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT02588235

    Ezetimibe and Atorvastatin Therapy on TCFA

    Not yet reported Xijing Hospital 100 participants Est. completion 2017-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02634580

    Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4

    Not yet reported Amgen 61 participants Est. completion 2018-05-26 35 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02642159

    Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

    Not yet reported Sanofi 413 participants Est. completion 2017-05-15 119 sites
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02682680

    Randomized Trial Comparing Colesevelam vs. Ezetimibe

    Not yet reported LMC Diabetes & Endocrinology Ltd. 200 participants Est. completion 2017-05-25 9 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02715726

    Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

    Not yet reported Sanofi 615 participants Est. completion 2018-08-06 62 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02730689

    A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

    Not yet reported Alvogen Korea 66 participants Est. completion 2015-01 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02741245

    A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

    Not yet reported Organon and Co 321 participants Est. completion 2017-01-18 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02748057

    A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)

    Not yet reported Organon and Co 135 participants Est. completion 2017-12-11 Stand-alone
    Other conditions: Hypercholesterolemia, Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02749994

    A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study)

    Not yet reported IlDong Pharmaceutical Co Ltd 396 participants Est. completion 2017-02 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Terminated NCT NCT02755194

    "Drugs in Lactation" Analysis Consortium

    The Hospital for Sick Children 68 participants Est. completion 2019-09-25 1 site
    Other conditions: Lactation
    View official trial listing →
  • Completed NCT NCT02767362

    A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

    Not yet reported UNC Lineberger Comprehensive Cancer Center 24 participants Est. completion 2019-09-26 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Status unknown NCT NCT02768545

    Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)

    Not yet reported Pontificia Universidad Catolica de Chile 12 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02772640

    Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

    Not yet reported Collegium Medicum w Bydgoszczy 83 participants Est. completion 2020-05 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02890992

    An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

    Not yet reported Sanofi 42 participants Est. completion 2019-02-22 16 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT02942602

    Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

    Not yet reported Yonsei University 58 participants Est. completion 2016-05-23 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Terminated NCT NCT02971033

    Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C

    Not yet reported VA Office of Research and Development 2 participants Est. completion 2021-03-31 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02984982

    Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

    Not yet reported Sanofi 206 participants Est. completion 2018-07-27 39 sites Stand-alone
    Other conditions: Hypercholesterolemia, Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT03001076

    Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)

    Not yet reported Esperion Therapeutics, Inc. 269 participants Est. completion 2018-02-12 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Atherosclerosis, Statin Adverse Reaction
    View official trial listing →
  • Status unknown NCT NCT03044665

    RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)

    Not yet reported Yonsei University 3780 participants Est. completion 2023-02-15 1 site Stand-alone
    Cardiovascular disease Other conditions: Cerebrovascular Disease, Peripheral Atherosclerotic Disease
    View official trial listing →
  • Completed NCT NCT03051100

    Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C

    Not yet reported Esperion Therapeutics, Inc. 63 participants Est. completion 2017-07-05 11 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03099278

    Ezetimibe for Patients With Chronic Hepatitis D

    Not yet reported Ziauddin Hospital 20 participants Est. completion 2017-10 1 site Stand-alone
    Other conditions: Chronic Hepatitis D
    View official trial listing →
  • Status unknown NCT NCT03105310

    Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D

    Not yet reported Aga Khan University 20 participants Est. completion 2017-06 Stand-alone
    Other conditions: Hepatitis D, Chronic
    View official trial listing →
  • Completed NCT NCT03110432

    Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

    GWT-TUD GmbH 1695 participants Est. completion 2024-04-17 3 sites
    Other conditions: Dyslipoproteinemias, Hypercholesterolemia, Familial, Familial Hypercholesterolemia - Homozygous, Familial Combined Hyperlipidemia
    View official trial listing →
  • Active, not recruiting NCT NCT03169985

    Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

    Not yet reported Samsung Medical Center 280 participants Est. completion 2027-01-28 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03204799

    Metagenomic Analysis of Human Gut Microbiota in Patients With Metabolic Diseases Including Diabetes

    Yonsei University 150 participants Est. completion 2019-12-16 1 site
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03217409

    A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

    Not yet reported Yuhan Corporation 85 participants Est. completion 2019-05-23 4 sites Stand-alone
    Other conditions: Diabetes Mellitus and Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03277079

    Low Dose Statins, Ezetimibe and Nutraceuticals

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2018-03-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03288038

    The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 382 participants Est. completion 2015-11-19 20 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03337308

    A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

    Not yet reported Esperion Therapeutics, Inc. 382 participants Est. completion 2018-07-18 5 sites Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT03355027

    Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 60 participants Est. completion 2023-11-30 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT03403556

    High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes

    Not yet reported Yuhan Corporation 140 participants Est. completion 2021-12 6 sites
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03430284

    Multifactorial Intervention on Diabetes (MIDiab Study)

    Not yet reported Shandong Provincial Hospital 6300 participants Est. completion 2022-12-31 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03434613

    Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease

    Not yet reported Yonsei University 64 participants Est. completion 2019-09-11 1 site Stand-alone
    MASLD Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03446261

    Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

    Not yet reported Yuhan Corporation 140 participants Est. completion 2019-03-05 2 sites Stand-alone
    Type 2 diabetes Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03494270

    High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

    Not yet reported Yuhan Corporation 270 participants Est. completion 2019-09-26 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03510715

    An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

    Not yet reported Sanofi 18 participants Est. completion 2020-02-17 10 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03510884

    An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

    Not yet reported Sanofi 153 participants Est. completion 2022-08-05 43 sites Stand-alone
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT03531905

    Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

    Not yet reported Esperion Therapeutics, Inc. 242 participants Est. completion 2019-06-18 4 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Cholesterolemia
    View official trial listing →
  • Completed NCT NCT03532854

    Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

    Not yet reported LG Chem 42 participants Est. completion 2019-01-30 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Status unknown NCT NCT03543774

    Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population

    Not yet reported Hue University of Medicine and Pharmacy 30 participants Est. completion 2020-10-15 1 site
    Chronic kidney disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03571087

    Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia

    Not yet reported Hanlim Pharm. Co., Ltd. 374 participants Est. completion 2015-09
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03597412

    Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

    Not yet reported Yuhan Corporation 236 participants Est. completion 2020-08-12 1 site Stand-alone
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03648788

    A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe

    IlDong Pharmaceutical Co Ltd 600 participants Est. completion 2024-08
    Other conditions: Mixed Dyslipidemia
    View official trial listing →
  • Withdrawn NCT NCT03750760

    Early Alirocumab to Reduce LDL-C in Myocardial Infarction

    Not yet reported Imperial College London Est. completion 2021-12 17 sites
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT03768427

    Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

    Not yet reported Organon and Co 454 participants Est. completion 2021-04-01 30 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03771053

    The Effect of Simvastatin Combined With Ezetimibe in Patients With Stable Angina and Diabetes

    Not yet reported Chinese PLA General Hospital 240 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT03847506

    Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

    Not yet reported HK inno.N Corporation 127 participants Est. completion 2020-12-02 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03867110

    An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

    Not yet reported Organon and Co 628 participants Est. completion 2001-07-27 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03867318

    Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

    Not yet reported Organon and Co 621 participants Est. completion 2001-11-16 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03872232

    Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan

    Not yet reported Addpharma Inc. 180 participants Est. completion 2020-08-12 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Hypertension
    View official trial listing →
  • Status unknown NCT NCT03877783

    DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes

    Not yet reported Umeå University 10 participants Est. completion 2023-06-30 1 site
    Type 2 diabetes Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03882892

    Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

    Not yet reported Organon and Co 400 participants Est. completion 2002-08-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03882905

    A Study of SCH 58235 (Ezetimibe) When Added to Ongoing Therapy With a Statin in Participants With Primary Hypercholesterolemia, Known Coronary Heart Disease, or Multiple Cardiovascular Risk Factors (P02173)

    Not yet reported Organon and Co 769 participants Est. completion 2001-07-27 Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03882996

    A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

    Not yet reported Organon and Co 432 participants Est. completion 2003-02-04 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03884127

    Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.

    Fifth Affiliated Hospital of Xinjiang Medical University 58 participants Est. completion 2019-09-30
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03884452

    Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

    Not yet reported Organon and Co 50 participants Est. completion 2001-05-24 Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03885921

    Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)

    Not yet reported Organon and Co 44 participants Est. completion 2003-07-08 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT03933293

    A Study to Evaluate the Safety and Efficacy of the PCSK9 Inhibitor AK102 in Patients With HoFH

    Not yet reported Akeso 10 participants Est. completion 2021-03-15 2 sites Stand-alone
    Other conditions: Homozygous Familial Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT03947866

    Ezetimibe-Rosuvastatin Evaluation Study

    Elpen Pharmaceutical Co. Inc. 600 participants Est. completion 2023-09-30 1 site
    Other conditions: Hypercholesterolemia, Hyperlipidemias, Combinations of Drugs; Dependence
    View official trial listing →
  • Completed NCT NCT03993236

    Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

    Not yet reported Keun-Sik Hong 584 participants Est. completion 2021-09-27 12 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04017338

    Transplantation Using Hepatitis C Positive Donors, A Safety Trial

    Not yet reported Jordan Feld 40 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Lung Transplant Infection, Heart Transplant Infection, Kidney Transplant Infection, Kidney Pancreas Infection, Hepatitis C
    View official trial listing →
  • Completed NCT NCT04056169

    Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

    Not yet reported Yuhan Corporation 50 participants Est. completion 2019-07-23 2 sites Stand-alone
    Other conditions: Acute Coronary Syndrome, Carotid Atherosclerotic Plaque With Inflammation
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04074551

    A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

    Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04080310

    Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin

    Not yet reported Seoul National University Bundang Hospital 270 participants Est. completion 2019-09-17 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04081844

    A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

    Not yet reported Hanmi Pharmaceutical Company Limited 31 participants Est. completion 2018-06-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04158076

    Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine

    Not yet reported Addpharma Inc. 131 participants Est. completion 2021-01-14 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04161001

    Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451

    Not yet reported Daewoong Pharmaceutical Co. LTD. 237 participants Est. completion 2022-02-02 1 site Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT04173403

    A Long-term Study of AK102 in Patients With Hypercholesterolemia

    Not yet reported Akeso 796 participants Est. completion 2023-02-17 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04173793

    A Study of PCSK9 Inhibitor AK102 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

    Not yet reported Akeso 109 participants Est. completion 2022-09-26 2 sites Stand-alone
    Other conditions: Heterozygous Familial Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT04185090

    To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

    Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2020-04 Stand-alone
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04289649

    K-924 Phase III Confirmatory Study

    Not yet reported Kowa Company, Ltd. 293 participants Est. completion 2020-11-21 3 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04289662

    K-924 Phase III Long Term Study

    Not yet reported Kowa Company, Ltd. 110 participants Est. completion 2021-08-07 13 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT04303377

    Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia Est. completion 2020-07-24 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04322266

    A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

    Not yet reported Hanmi Pharmaceutical Company Limited 61 participants Est. completion 2019-02-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04358432

    A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia

    Not yet reported Akeso 262 participants Est. completion 2021-02-25 2 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04369664

    CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

    Not yet reported NYU Langone Health 151 participants Est. completion 2023-10-19 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04397653

    Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients

    Not yet reported Policlinico Casilino ASL RMB 50 participants Est. completion 2020-12-14 1 site Stand-alone
    Chronic kidney disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT04433533

    Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia

    Not yet reported Yonsei University 200 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Left Ventricular Diastolic Dysfunction, Hyperlipidemias
    View official trial listing →
  • Status unknown NCT NCT04455581

    A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 8 participants Est. completion 2021-08-31 Stand-alone
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Active, not recruiting NCT NCT04508907

    A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients

    Not yet reported Mayo Clinic 200 participants Est. completion 2026-11-01 1 site
    Other conditions: Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection
    View official trial listing →
  • Active, not recruiting NCT NCT04579367

    Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 5000 participants Est. completion 2026-10-30 443 sites
    Other conditions: Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT04584736

    To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

    Not yet reported JW Pharmaceutical 283 participants Est. completion 2020-10-12 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Status unknown NCT NCT04589351

    Kidney Fat in Type 2 Diabetes and the Effects of Ezetimibe

    Not yet reported Steno Diabetes Center Copenhagen 60 participants Est. completion 2022-05 1 site
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT04626973

    Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

    Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT04638400

    Anti-inflammatory Effects of Simvastatin

    Not yet reported paresh Dandona 10 participants Est. completion 2021-11-01 1 site
    Other conditions: Inflammation, Atherosclerosis, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04643093

    Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

    Not yet reported Orient Pharma Co., Ltd. 390 participants Est. completion 2021-10-05 34 sites
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT04656028

    Genetic Testing and Motivational Counseling for FH

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 180 participants Est. completion 2025-03-30 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2, Hypercholesterolemia, Familial, 3, Hypercholesterolemia, Familial, 4, Hypercholesterolemia, Familial, 4, Autosomal Recessive, Familial Hypercholesterolemia With Hyperlipemia, Hypercholesterolemia, Autosomal Dominant, Type B, Hypercholesterolemia, Autosomal Dominant, Hypercholesterolemia, Autosomal Dominant, 3, Apolipoprotein B-100, Familial Defective, Genetic Testing, Motivational Interviewing, Therapeutic Adherence, Therapeutic Adherence and Compliance, Treatment Adherence, Medication Adherence, Treatment Adherence and Compliance, Patient Adherence, Compliance, Patient Compliance, Familial Hypercholesterolemia, Familial Hypercholesterolemia - Heterozygous, Adherence, Patient, Adherence, Medication, Adherence
    View official trial listing →
  • Status unknown NCT NCT04659070

    To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia

    Not yet reported Hanlim Pharm. Co., Ltd. 156 participants Est. completion 2022-05-19 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia, Hypertension
    View official trial listing →
  • Status unknown NCT NCT04659525

    Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia

    Not yet reported Policlinico Casilino ASL RMB 50 participants Est. completion 2021-12-30 1 site Stand-alone
    Chronic kidney disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04669041

    A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

    Not yet reported Sanofi 305 participants Est. completion 2022-06-15 40 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04700436

    Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

    Not yet reported Seoul National University Hospital 146 participants Est. completion 2024-02-13 26 sites Stand-alone
    Type 2 diabetes Other conditions: Endocrine System Diseases, Nutritional and Metabolic Diseases, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04701242

    Ezetimibe Utilization Early After Acute Myocardial Infarction, "EzAMI Trial"

    Not yet reported Cairo University 500 participants Est. completion 2025-12 1 site
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04719221

    Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome

    Not yet reported Korea University Anam Hospital 60 participants Est. completion 2024-12 1 site
    Other conditions: Clinical Trial, Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT04737408

    Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)

    Not yet reported Bjarne Linde Noergaard 120 participants Est. completion 2023-08 3 sites
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT04755413

    The Precision CAD Trial

    Not yet reported Emory University 276 participants Est. completion 2028-12 5 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04770389

    Randomized Study of Obicetrapib in Combination With Ezetimibe

    Not yet reported NewAmsterdam Pharma 112 participants Est. completion 2021-06-30 9 sites Stand-alone
    Other conditions: Dyslipidemias, High Cholesterol, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04807400

    Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

    Not yet reported Novartis Pharmaceuticals 892 participants Est. completion 2023-01-13 17 sites Stand-alone
    Cardiovascular disease Other conditions: Elevated Low Density Lipoprotein Cholesterol
    View official trial listing →
  • Status unknown NCT NCT04814589

    Bioequivalence of Ezetimibe Tablets in Healthy Subjects

    Not yet reported Cao Yu 96 participants Est. completion 2021-07-31 1 site Stand-alone
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Completed NCT NCT04826354

    Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

    Not yet reported Korea University Anam Hospital 582 participants Est. completion 2023-06-28 2 sites
    Other conditions: Atheroscleroses, Coronary
    View official trial listing →
  • Completed NCT NCT04829149

    Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

    Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04844996

    Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis

    Not yet reported Mersin University 18 participants Est. completion 2021-01-31 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Active, not recruiting NCT NCT04862260

    Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

    Not yet reported CHU de Quebec-Universite Laval 3 participants Est. completion 2026-12-31 2 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT04862962

    Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia

    Laboratorios Silanes S.A. de C.V. 120 participants Est. completion 2022-02-15 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04895059

    Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

    Not yet reported Laboratorios Silanes S.A. de C.V. 36 participants Est. completion 2018-01-22 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04895098

    Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD

    Akrikhin 1000 participants Est. completion 2022-07-08 31 sites
    Cardiovascular disease Other conditions: Lipid Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT04900155

    Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19

    Not yet reported Penza State University 45 participants Est. completion 2024-12 1 site
    Other conditions: STEMI, Covid19, NSTEMI
    View official trial listing →
  • Status unknown NCT NCT05080140

    Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

    Misr University for Science and Technology 3 participants Est. completion 2022-03-20 1 site
    Other conditions: Hyperlipidemia; Mixed
    View official trial listing →
  • Status unknown NCT NCT05081336

    Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry

    University Clinical Centre of Republic of Srpska 500 participants Est. completion 2023-03 1 site
    Other conditions: Acute Coronary Syndrome, Dyslipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT05088759

    Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein Management

    Not yet reported Brigham and Women's Hospital 400 participants Est. completion 2026-06-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Hyperlipemia, Mixed
    View official trial listing →
  • Completed NCT NCT05095896

    The Serum Lipid Profiles in ITP: a Retrospective Study

    Ming Hou 457 participants Est. completion 2020-12-01 1 site
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT05131997

    A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

    Not yet reported Addpharma Inc. 290 participants Est. completion 2022-06-08 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT05184530

    In-hospital Initiation of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction

    First Affiliated Hospital Xi'an Jiaotong University 7556 participants Est. completion 2021-12
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT05255094

    A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia

    Not yet reported Akeso 464 participants Est. completion 2022-06-22 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT05255458

    A Study to Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

    Not yet reported Akeso 122 participants Est. completion 2023-01-09 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT05260411

    A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

    Not yet reported Akeso 246 participants Est. completion 2022-12-19 2 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT05263778

    Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study

    Not yet reported Kaiser Permanente 500 participants Est. completion 2023-12 1 site
    Cardiovascular disease Other conditions: NSTEMI, STEMI
    View official trial listing →
  • Completed NCT NCT05266586

    Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

    Not yet reported NewAmsterdam Pharma 119 participants Est. completion 2022-09-08 16 sites Stand-alone
    Other conditions: Dyslipidemias, High Cholesterol, Hypercholesterolemia
    View official trial listing →
  • Active, not recruiting NCT NCT05361421

    Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

    Not yet reported Yonsei University 1200 participants Est. completion 2027-10-15 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05368545

    Influence of Lipid Lowering on Impaired Coronary Flow

    Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05372380

    A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 32 participants Est. completion 2022-06-30 1 site
    Other conditions: Hypertension, Hypercholesterinemia
    View official trial listing →
  • Status unknown NCT NCT05381870

    Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 48 participants Est. completion 2022-12-30 Stand-alone
    Other conditions: Pharmacokinetics, Safety
    View official trial listing →
  • Active, not recruiting NCT NCT05462262

    Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 2900 participants Est. completion 2029-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05481385

    Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 48 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Pharmacokinetics, Safety
    View official trial listing →
  • Completed NCT NCT05543122

    Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants

    The Hospital for Sick Children 39 participants Est. completion 2024-03-31 1 site
    Other conditions: Breast Feeding
    View official trial listing →
  • Completed NCT NCT05546398

    SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI®

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 500 participants Est. completion 2022-11-17 63 sites
    Other conditions: Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05559606

    An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

    Boryung Pharmaceutical Co., Ltd 1839 participants Est. completion 2025-07-30 1 site
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Enrolling by invitation NCT NCT05579626

    Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

    Not yet reported Seung-Whan Lee, M.D., Ph.D. 4000 participants Est. completion 2030-12-31 31 sites
    Cardiovascular disease Other conditions: Pre Diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT05587621

    Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

    Not yet reported Jena University Hospital 300 participants Est. completion 2026-12-31 10 sites
    Cardiovascular disease Other conditions: LDL-cholesterol
    View official trial listing →
  • Status unknown NCT NCT05613400

    Statin and Bone Health

    Not yet reported The University of Hong Kong 240 participants Est. completion 2025-06-30 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05614765

    Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment

    Daewoong Pharmaceutical Co. LTD. 18000 participants Est. completion 2025-12-31 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT05624658

    Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS

    Not yet reported Samara Regional Cardiology Dispensary 200 participants Est. completion 2024-05 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05661552

    Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI

    Not yet reported Yonsei University 108 participants Est. completion 2025-02-05 1 site Stand-alone
    Other conditions: Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
    View official trial listing →
  • Completed NCT NCT05681247

    Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 59 participants Est. completion 2018-03-07 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT05761444

    Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

    Not yet reported Organon and Co 137 participants Est. completion 2024-10-15 7 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05763875

    Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

    Not yet reported Novartis Pharmaceuticals 350 participants Est. completion 2024-06-20 42 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT05795517

    Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）

    Not yet reported Haisco Pharmaceutical Group Co., Ltd. 210 participants Est. completion 2024-03-01 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Withdrawn NCT NCT05798390

    Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia

    Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Est. completion 2026-04-01
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT05884502

    A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke

    Not yet reported Korea University Anam Hospital 330 participants Est. completion 2024-12-31 3 sites Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT05889143

    A Study to Evaluate the Efficacy and Safety of CREZET Tablet

    Daewoong Pharmaceutical Co. LTD. 15000 participants Est. completion 2026-03-01 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Active, not recruiting NCT NCT05910476

    Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

    Not yet reported Yonsei University 200 participants Est. completion 2026-09-22 1 site
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05930028

    A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

    Not yet reported Boryung Pharmaceutical Co., Ltd 148 participants Est. completion 2024-09-05 1 site Stand-alone
    Other conditions: Essential Hypertension, Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT05970679

    Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

    Not yet reported Daewon Pharmaceutical Co., Ltd. 252 participants Est. completion 2023-04-13 1 site Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05974345

    In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

    Novartis Pharmaceuticals 204691 participants Est. completion 2023-12-15 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06005597

    Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

    Not yet reported NewAmsterdam Pharma 407 participants Est. completion 2024-10-16 45 sites Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia, High Cholesterol
    View official trial listing →
  • Completed NCT NCT06021951

    Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women

    Not yet reported Esperion Therapeutics, Inc. 16 participants Est. completion 2024-03-22 1 site Stand-alone
    Other conditions: Healthy Lactating Women
    View official trial listing →
  • Completed NCT NCT06050291

    Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

    Not yet reported NewAmsterdam Pharma 28 participants Est. completion 2024-04-07 1 site Stand-alone
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Not yet recruiting NCT NCT06096909

    Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

    Not yet reported China National Center for Cardiovascular Diseases 3684 participants Est. completion 2027-11-01
    Other conditions: Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT06225635

    A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab

    Not yet reported Shin Poong Pharmaceutical Co. Ltd. 60 participants Est. completion 2022-03-07 1 site Stand-alone
    Other conditions: Hyperlipidemias
    View official trial listing →
  • Withdrawn NCT NCT06280976

    Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)

    Not yet reported University of Louisville Est. completion 2025-01-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Atherosclerosis, Heart Attack
    View official trial listing →
  • Active, not recruiting NCT NCT06305559

    A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque

    Not yet reported NewAmsterdam Pharma 300 participants Est. completion 2028-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Lipidemia, Plaque, Atherosclerotic
    View official trial listing →
  • Active, not recruiting NCT NCT06317051

    Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

    Not yet reported Kirby Institute 300 participants Est. completion 2027-12 10 sites
    Other conditions: HIV Infections, Weight Gain
    View official trial listing →
  • Status unknown NCT NCT06381947

    Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients

    Not yet reported University of Salerno 130 participants Est. completion 2025-06-30 Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Lipid Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT06431763

    A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

    Not yet reported Novartis Pharmaceuticals 402 participants Est. completion 2026-01-02 55 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT06450366

    A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)

    Not yet reported Merck Sharp & Dohme LLC 301 participants Est. completion 2025-03-28 35 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT06547359

    A Study to Evaluate Drug-Drug Interactions of Obicetrapib Tablets and Ezetimibe Tablets in Healthy Adult Subjects

    Not yet reported NewAmsterdam Pharma 94 participants Est. completion 2024-11-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06567418

    Retrospective Analysis of the Effect of In-hospital Initiation of PCSK9i on Clinical Outcomes in Chinese ACS Patients

    Yun Dai Chen 10000 participants Est. completion 2025-01-31 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT06578676

    To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

    Not yet reported Hyundai Pharm 56 participants Est. completion 2024-11-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Dyslipidemias
    View official trial listing →
  • Enrolling by invitation NCT NCT06646354

    To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia

    Not yet reported Hyundai Pharm 125 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Hypertension, Primary Hypercholesterolaemia
    View official trial listing →
  • Completed NCT NCT06647238

    Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

    Not yet reported Wake Forest University Health Sciences 80 participants Est. completion 2025-05-27 1 site Stand-alone
    Cardiovascular disease Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT06740552

    Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

    Shanghai Zhongshan Hospital 1862 participants Est. completion 2025-10-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06742853

    A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.

    Not yet reported AstraZeneca 81 participants Est. completion 2025-10-29 3 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Not yet recruiting NCT NCT06821711

    Optimal LDL-C Target in High-risk Patients After PCI

    Not yet reported Xijing Hospital 12000 participants Est. completion 2029-08-15 1 site Stand-alone
    Other conditions: Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
    View official trial listing →
  • Not yet recruiting NCT NCT06854523

    Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)

    Not yet reported Yun Dai Chen 300 participants Est. completion 2026-12-31 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06866509

    To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients

    Daewoong Pharmaceutical Co. LTD. 3000 participants Est. completion 2024-02-28 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Not yet recruiting NCT NCT07084259

    Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study

    Not yet reported Hanyang University Seoul Hospital 352 participants Est. completion 2030-07
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07174375

    PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 478 participants Est. completion 2027-12-15 12 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07182383

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-11-24 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT07201545

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2025-12-10 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT07219602

    A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

    Not yet reported NewAmsterdam Pharma 300 participants Est. completion 2028-06 55 sites Stand-alone
    Type 2 diabetesMetabolic syndrome Other conditions: Lipidemia
    View official trial listing →
  • Completed NCT NCT07235189

    A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-01-28 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT07255820

    Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

    Not yet reported Bahria University 126 participants Est. completion 2026-06-30 1 site
    Type 2 diabetes Other conditions: Hypercholesterolemia / Elevated LDL Cholesterol
    View official trial listing →
  • Not yet recruiting NCT NCT07256171

    COAST Study - Cholesterol Optimization After Stroke

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 500 participants Est. completion 2026-12-31
    Cardiovascular disease Other conditions: Cerebral Hemorrhage
    View official trial listing →
  • Completed NCT NCT07268625

    Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin

    Not yet reported Daiichi Sankyo 58 participants Est. completion 2026-02-24 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Not yet recruiting NCT NCT07341958

    INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)

    Not yet reported Beijing Tiantan Hospital 242 participants Est. completion 2027-08-30 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07432516

    Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial

    Not yet reported Yonsei University 4400 participants Est. completion 2033-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07440381

    triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

    Not yet reported Heart Care Foundation 600 participants Est. completion 2027-08 35 sites Stand-alone
    Other conditions: Acute Coronary Syndromes, Secondary Prevention, Lipids
    View official trial listing →
  • Active, not recruiting NCT NCT07442630

    Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

    Not yet reported JW Pharmaceutical 88 participants Est. completion 2026-11-30 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07445542

    Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia

    JW Pharmaceutical 6927 participants Est. completion 2025-05-13 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07474649

    A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

    Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-alone
    Other conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07489183

    A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

    Dong Wha Pharmaceutical Co. Ltd. 641 participants Est. completion 2023-09-07 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07508254

    Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

    Not yet reported Punjab Institute of Cardology 120 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes (ACS), Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07515560

    Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study

    Daewoong Pharmaceutical Co. LTD. 12000 participants Est. completion 2027-12-31 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT07564726

    Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

    Not yet reported Celltrion Pharm, Inc. 163 participants Est. completion 2024-02-13 21 sites Stand-alone
    Other conditions: Hypertension, Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07605130

    Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial

    Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-alone
    Other conditions: Intracranial Arteriosclerosis, Cognitive Impairment
    View official trial listing →
  • Not yet recruiting NCT NCT07615296

    Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment

    Not yet reported Beijing Anzhen Hospital 6000 participants Est. completion 2031-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT07622433

    A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy Adults

    Not yet reported AstraZeneca 18 participants Est. completion 2026-09-07 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07626840

    Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31 Stand-alone
    Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Not yet recruiting NCT NCT07674524

    Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC

    Sun Yat-sen University 160 participants Est. completion 2029-12-31 1 site
    Other conditions: Non-Small Cell Lung Cancer (NSCLC), Hyperlipidemia, ALK Gene Mutation, ALK-positive
    View official trial listing →
  • Not yet recruiting NCT NCT07684469

    Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

    Not yet reported Novartis Pharmaceuticals 300 participants Est. completion 2028-10-31 Stand-alone
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07685054

    To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or 'Fimasartan, Atorvastatin and Ezetimibe'.

    Boryung Pharmaceutical Co., Ltd 12700 participants Est. completion 2029-08-15
    Other conditions: Essential Hypertension, Primary Hypercholesterolemia
    View official trial listing →
  • Not yet recruiting NCT NCT07752758

    Ezetimibe for Arrhythmia Recurrence After AF Ablation

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 120 participants Est. completion 2028-06-30 Stand-alone
    Other conditions: Atrial Fibrillation, Post-Catheter Ablation Atrial Arrhythmia Recurrence
    View official trial listing →
  • Not yet recruiting NCT NCT07784621

    A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults

    Not yet reported Huons Co., Ltd. 30 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07799779

    Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome

    Not yet reported Seoul National University Bundang Hospital 294 participants Est. completion 2029-09 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes (ACS)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ezetimibe, Ezetimibe and Simvastatin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.